• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于生物应用的工程聚合物材料:克服生物-纳米界面的挑战

Engineered Polymeric Materials for Biological Applications: Overcoming Challenges of the Bio-Nano Interface.

作者信息

Simpson Joshua D, Smith Samuel A, Thurecht Kristofer J, Such Georgina

机构信息

Centre for Advanced Imaging, Australian Institute for Bioengineering and Nanotechnology, ARC Centre of Excellence in Convergent Bio-Nano Science and Technology and ARC Training Centre for Innovation in Biomedical Imaging Technology, the University of Queensland, St Lucia, QLD, 4072, Australia.

School of Chemistry, University of Melbourne, Parkville, VIC, 3010, Australia.

出版信息

Polymers (Basel). 2019 Sep 2;11(9):1441. doi: 10.3390/polym11091441.

DOI:10.3390/polym11091441
PMID:31480780
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6780590/
Abstract

Nanomedicine has generated significant interest as an alternative to conventional cancertherapy due to the ability for nanoparticles to tune cargo release. However, while nanoparticletechnology has promised significant benefit, there are still limited examples of nanoparticles inclinical practice. The low translational success of nanoparticle research is due to the series ofbiological roadblocks that nanoparticles must migrate to be effective, including blood and plasmainteractions, clearance, extravasation, and tumor penetration, through to cellular targeting,internalization, and endosomal escape. It is important to consider these roadblocks holistically inorder to design more effective delivery systems. This perspective will discuss how nanoparticlescan be designed to migrate each of these biological challenges and thus improve nanoparticledelivery systems in the future. In this review, we have limited the literature discussed to studiesinvestigating the impact of polymer nanoparticle structure or composition on therapeutic deliveryand associated advancements. The focus of this review is to highlight the impact of nanoparticlecharacteristics on the interaction with different biological barriers. More specific studies/reviewshave been referenced where possible.

摘要

由于纳米颗粒能够调节药物释放,纳米医学作为传统癌症治疗的替代方法已引起了广泛关注。然而,尽管纳米颗粒技术有望带来显著益处,但在临床实践中纳米颗粒的应用实例仍然有限。纳米颗粒研究在转化应用方面成功率较低,这是因为纳米颗粒要发挥作用必须克服一系列生物学障碍,包括与血液和血浆的相互作用、清除、渗出、肿瘤渗透,以及细胞靶向、内化和内体逃逸等。为了设计出更有效的递送系统,全面考虑这些障碍非常重要。本文将探讨如何设计纳米颗粒以克服这些生物学挑战,从而在未来改进纳米颗粒递送系统。在本综述中,我们将所讨论的文献限定为研究聚合物纳米颗粒结构或组成对治疗递送的影响及相关进展的研究。本综述的重点是突出纳米颗粒特性对与不同生物屏障相互作用的影响。在可能的情况下,已引用了更具体的研究/综述。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff46/6780590/99c87a244951/polymers-11-01441-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff46/6780590/3ce834fbcae4/polymers-11-01441-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff46/6780590/602270ffd39f/polymers-11-01441-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff46/6780590/cc53c90171e5/polymers-11-01441-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff46/6780590/1a2abb4327ed/polymers-11-01441-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff46/6780590/99c87a244951/polymers-11-01441-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff46/6780590/3ce834fbcae4/polymers-11-01441-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff46/6780590/602270ffd39f/polymers-11-01441-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff46/6780590/cc53c90171e5/polymers-11-01441-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff46/6780590/1a2abb4327ed/polymers-11-01441-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ff46/6780590/99c87a244951/polymers-11-01441-g005.jpg

相似文献

1
Engineered Polymeric Materials for Biological Applications: Overcoming Challenges of the Bio-Nano Interface.用于生物应用的工程聚合物材料:克服生物-纳米界面的挑战
Polymers (Basel). 2019 Sep 2;11(9):1441. doi: 10.3390/polym11091441.
2
Optimal delivery strategies for nanoparticle-mediated mRNA delivery.纳米颗粒介导的 mRNA 递呈的最佳递送策略。
J Mater Chem B. 2023 Mar 8;11(10):2063-2077. doi: 10.1039/d2tb02455a.
3
The Nano-Bio Interactions of Nanomedicines: Understanding the Biochemical Driving Forces and Redox Reactions.纳米药物的纳-生物相互作用:理解生化驱动力和氧化还原反应。
Acc Chem Res. 2019 Jun 18;52(6):1507-1518. doi: 10.1021/acs.accounts.9b00126. Epub 2019 May 31.
4
Concepts of nanoparticle cellular uptake, intracellular trafficking, and kinetics in nanomedicine.纳米颗粒细胞摄取、细胞内转运和纳米医学中动力学的概念。
Adv Drug Deliv Rev. 2019 Mar 15;143:68-96. doi: 10.1016/j.addr.2019.04.008. Epub 2019 Apr 22.
5
T Cell-Targeting Nanoparticle Drug Delivery Systems: Considerations for Rational Design.靶向T细胞的纳米颗粒药物递送系统:合理设计的考量
ACS Nano. 2021 Mar 23;15(3):3736-3753. doi: 10.1021/acsnano.0c09514. Epub 2021 Feb 18.
6
Delivering colloidal nanoparticles to mammalian cells: a nano-bio interface perspective.将胶体纳米颗粒递送至哺乳动物细胞:纳米-生物界面的视角。
Adv Healthc Mater. 2014 Jul;3(7):957-76. doi: 10.1002/adhm.201300602. Epub 2014 Jan 20.
7
Controlling endosomal escape using nanoparticle composition: current progress and future perspectives.利用纳米颗粒组成控制内涵体逃逸:当前进展和未来展望。
Nanomedicine (Lond). 2019 Jan;14(2):215-223. doi: 10.2217/nnm-2018-0326. Epub 2018 Dec 4.
8
Nanoescapology: progress toward understanding the endosomal escape of polymeric nanoparticles.纳米逃逸学:理解聚合物纳米颗粒内体逃逸的研究进展
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017 Sep;9(5). doi: 10.1002/wnan.1452. Epub 2017 Feb 3.
9
Nanotherapeutics in oral and parenteral drug delivery: Key learnings and future outlooks as we think small.口服和肠胃外药物递送中的纳米治疗学:当我们着眼于小处时的关键学习和未来展望
J Control Release. 2018 Feb 28;272:159-168. doi: 10.1016/j.jconrel.2018.01.009. Epub 2018 Jan 19.
10
Smart Nanosystems for Overcoming Multiple Biological Barriers in Cancer Nanomedicines Transport: Design Principles, Progress, and Challenges.智能纳米系统克服癌症纳米医学输送中的多重生物学障碍:设计原则、进展和挑战。
Small. 2023 Jul;19(28):e2207973. doi: 10.1002/smll.202207973. Epub 2023 Mar 27.

引用本文的文献

1
Nanocarrier drug delivery systems for gynecological cancer therapeutics.用于妇科癌症治疗的纳米载体药物递送系统。
J Control Release. 2025 Sep 10;385:114028. doi: 10.1016/j.jconrel.2025.114028. Epub 2025 Jul 17.
2
Polymeric Nanoparticles for Drug Delivery.高分子纳米粒药物递送系统
Chem Rev. 2024 May 8;124(9):5505-5616. doi: 10.1021/acs.chemrev.3c00705. Epub 2024 Apr 16.
3
Nano-enabled antimicrobial thin films: design and mechanism of action.纳米抗菌薄膜:设计与作用机制

本文引用的文献

1
Sequential Drug Release to Modulate Collagen Synthesis and Promote Micelle Penetration in Tumors.顺序药物释放以调节胶原蛋白合成并促进胶束在肿瘤中的渗透。
ACS Biomater Sci Eng. 2019 Mar 11;5(3):1343-1353. doi: 10.1021/acsbiomaterials.8b01600. Epub 2019 Feb 12.
2
Interactions of organic nanoparticles with proteins in physiological conditions.有机纳米颗粒在生理条件下与蛋白质的相互作用。
J Mater Chem B. 2017 Jun 21;5(23):4393-4405. doi: 10.1039/c7tb00146k. Epub 2017 May 19.
3
Designing nanoparticles with improved tumor penetration: surface properties from the molecular architecture viewpoint.
RSC Adv. 2024 Feb 9;14(8):5290-5308. doi: 10.1039/d3ra07884a. eCollection 2024 Feb 7.
4
MMP-2 Silencing through siRNA Loaded Positively-Charged Nanoparticles (AcPEI-NPs) Counteracts Chondrocyte De-Differentiation.通过负载小干扰RNA的带正电荷纳米颗粒(乙酰化聚乙烯亚胺纳米颗粒)沉默基质金属蛋白酶-2可对抗软骨细胞去分化。
Polymers (Basel). 2023 Feb 25;15(5):1172. doi: 10.3390/polym15051172.
5
time course of organ uptake and blood-brain-barrier permeation of poly(L-lactide) and poly(perfluorodecyl acrylate) nanoparticles with different surface properties in unharmed and brain-traumatized rats.聚(L-丙交酯)和聚(全氟癸基丙烯酸酯)纳米颗粒在未受伤和脑外伤大鼠体内的器官摄取及血脑屏障渗透的时间进程,这些纳米颗粒具有不同的表面性质。
Front Neurol. 2023 Feb 6;14:994877. doi: 10.3389/fneur.2023.994877. eCollection 2023.
6
Assessing the In Vivo Biocompatibility of Molecularly Imprinted Polymer Nanoparticles.评估分子印迹聚合物纳米颗粒的体内生物相容性
Polymers (Basel). 2022 Oct 28;14(21):4582. doi: 10.3390/polym14214582.
7
Physiologically Based Pharmacokinetic Modeling of Nanoparticle Biodistribution: A Review of Existing Models, Simulation Software, and Data Analysis Tools.基于生理学的纳米颗粒生物分布的药代动力学模型:现有模型、模拟软件和数据分析工具的综述。
Int J Mol Sci. 2022 Oct 19;23(20):12560. doi: 10.3390/ijms232012560.
8
Nanocarriers for Drug Delivery: An Overview with Emphasis on Vitamin D and K Transportation.用于药物递送的纳米载体:重点关注维生素D和K转运的概述
Nanomaterials (Basel). 2022 Apr 17;12(8):1376. doi: 10.3390/nano12081376.
9
Cyanine-5-Driven Behaviours of Hyperbranched Polymers Designed for Therapeutic Delivery Are Cell-Type Specific and Correlated with Polar Lipid Distribution in Membranes.用于治疗递送的超支化聚合物的花菁-5驱动行为具有细胞类型特异性,且与膜中极性脂质分布相关。
Nanomaterials (Basel). 2021 Jul 2;11(7):1745. doi: 10.3390/nano11071745.
10
Biomimetic Microfluidic Platforms for the Assessment of Breast Cancer Metastasis.用于评估乳腺癌转移的仿生微流控平台
Front Bioeng Biotechnol. 2021 Mar 11;9:633671. doi: 10.3389/fbioe.2021.633671. eCollection 2021.
设计具有改善的肿瘤穿透性的纳米粒子:从分子架构观点看表面性质。
J Mater Chem B. 2019 Feb 14;7(6):953-964. doi: 10.1039/c8tb03034k. Epub 2019 Jan 18.
4
Nanoparticle-proteome in vitro and in vivo.纳米颗粒-蛋白质组的体外和体内研究
J Mater Chem B. 2018 Oct 14;6(38):6026-6041. doi: 10.1039/c8tb01634h. Epub 2018 Aug 16.
5
DePEGylation strategies to increase cancer nanomedicine efficacy.去聚乙二醇化策略提高癌症纳米医学疗效。
Nanoscale Horiz. 2019 Mar 1;4(2):378-387. doi: 10.1039/c8nh00417j. Epub 2018 Dec 11.
6
Cellular Targeting of Bispecific Antibody-Functionalized Poly(ethylene glycol) Capsules: Do Shape and Size Matter?双特异性抗体功能化聚乙二醇胶囊的细胞靶向:形状和大小重要吗?
ACS Appl Mater Interfaces. 2019 Aug 14;11(32):28720-28731. doi: 10.1021/acsami.9b10304. Epub 2019 Aug 1.
7
Carboxylated Cy5-Labeled Comb Polymers Passively Diffuse the Cell Membrane and Target Mitochondria.羧基化 Cy5 标记梳状聚合物被动扩散穿过细胞膜并靶向线粒体。
ACS Appl Mater Interfaces. 2019 Aug 28;11(34):31302-31310. doi: 10.1021/acsami.9b09395. Epub 2019 Aug 16.
8
Prevention of Dominant IgG Adsorption on Nanocarriers in IgG-Enriched Blood Plasma by Clusterin Precoating.通过簇集蛋白预包被防止富含IgG的血浆中纳米载体上的优势IgG吸附。
Adv Sci (Weinh). 2019 Apr 4;6(10):1802199. doi: 10.1002/advs.201802199. eCollection 2019 May 17.
9
Mathematical modeling in cancer nanomedicine: a review.癌症纳米医学中的数学建模:综述。
Biomed Microdevices. 2019 Apr 4;21(2):40. doi: 10.1007/s10544-019-0380-2.
10
Possibilities and Limitations of Different Separation Techniques for the Analysis of the Protein Corona.不同分离技术在分析蛋白质冠层中的可能性和局限性。
Angew Chem Int Ed Engl. 2019 Sep 9;58(37):12787-12794. doi: 10.1002/anie.201902323. Epub 2019 Jul 24.